{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-046009","form_type":"8-K","ticker":"NUWE","cik":"0001506492","company_name":"Nuwellis, Inc.","filed_at":"2024-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.626275+00:00","generated_at":"2026-05-30T01:49:03.768851+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Nuwellis Q3 revenue $2.4M, net income $2.4M; CMS reimbursement up 297%","bullets":["Revenue $2.4M, down 2% YoY; pediatrics revenue grew 28% YoY.","Gross margin 70% vs 57.3% YoY; operating expenses down 30% YoY.","Net income attributable to common $2.4M ($1.74/share) vs loss $3.4M; includes $3.9M warrant liability benefit.","CMS increased Aquadex facility fee reimbursement 297% to $1,639/day, effective Jan 1, 2025.","Cash $1.9M, no debt; $5.1M gross proceeds from November warrant exercise."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-046009","json":"https://secwatch.observer/filing/0001140361-24-046009.json","markdown":"https://secwatch.observer/filing/0001140361-24-046009.md","text":"https://secwatch.observer/filing/0001140361-24-046009.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1506492/000114036124046009/0001140361-24-046009-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1506492/000114036124046009/ef20038370_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T01:49:03.768851+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}